Skip to content

A randomized controlled study of the treatment of radiation induced skin injury by Erhuang Decoction

Clinical Study of External Therapy of Chinese Medicine for Side Effects of Cancer Treatments in China-Israe

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040705
Enrollment
Unknown
Registered
2020-12-08
Start date
2020-12-10
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation induced skin injury

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as a malignant tumor by pathology or cytology; 2. Patients with grade 2 or 3 radiation-induced skin injury after radiotherapy (Using RTOG acute radiation injury classification standard, Tumor radiotherapy, 3rd Edition, edited by Yin Weibai and Gu Xianzhi); 3. Aged between 18 and 70 years; 4. No history of systematic use of corticosteroids and antihistamines in the last 2 weeks and no history of external use of such drugs within 1 week.

Exclusion criteria

Exclusion criteria: 1. Patients with systemic or contact drug allergy history; 2. Patients with local skin lesions complicated with bacterial or fungal infection; 3. Patients with severe endocrine, cardiovascular, blood, liver and kidney diseases and low immune function.

Design outcomes

Primary

MeasureTime frame
Skin lesion remission rate;

Secondary

MeasureTime frame
Symptoms, signs and TCM Syndromes of skin lesions;Quality of life;Changes in the degree of pain;

Countries

China

Contacts

Public ContactYing Zhang

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

zylzy501@163.com+86 13311027150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026